Get started
Author

Midori Matsuo

ORCID: 0009-0001-6143-1205
Observed ORCID: 0009-0001-6143-1205
OpenAlex ID: A5077715698
Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study)
2024 · Shinnosuke Takemoto, Minoru Fukuda, et al. · Translational Lung Cancer Research · 5
Cisplatin re-challenge following recovery from carboplatin-induced, biopsy-proven acute tubular necrosis in a 57-year-old patient with squamous-transformed non-small cell lung cancer: a case report
2026 · Toru Morikawa, Yosuke Dotsu, et al. · Translational Lung Cancer Research · 3
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET
2025 · Fumiko Hayashi, Midori Matsuo, et al. · Journal of Thoracic Disease · 2
Radiotherapy-Associated Systemic Antitumor Responses Beyond the Classical Abscopal Paradigm
2026 · Yosuke Dotsu, Kazumasa Akagi, et al. · Cancers · 1
PDF
Regression of a Non-Irradiated Lung Adenocarcinoma During Glioblastoma-Directed Chemoradiotherapy: A Case Report
2026 · Mizuki Iwanaga, Yosuke Dotsu, et al. · Current Oncology · 1
PDF
Genomic landscape of pleural mesothelioma in Japanese patients: A comprehensive analysis using nationwide database
2026 · Hirokazu Taniguchi, Kazumasa Akagi, et al. · Translational Oncology · 1
Acute amivantamab-induced myocardial injury in a patient with epidermal growth factor receptor-mutant lung cancer: a first case report
2025 · Seiya Kaneko, Yosuke Dotsu, et al. · Frontiers in Oncology · 1
PDF
Abstract 4286: CHK1 as a novel therapeutic target for pleural mesothelioma
2025 · Kazumasa Akagi, Hirokazu Taniguchi, et al. · Cancer Research · 1
Cerebral Amyloid Angiopathy-Related Inflammation Mimicking Leptomeningeal Metastasis After Resected Lung Adenocarcinoma: A Case Report Highlighting Dynamic Diagnostic Reassessment
2026 · Kodai Shigeyama, Yosuke Dotsu, et al. · Current Oncology
Real-world pharmacokinetics of ramucirumab in combination with erlotinib and docetaxel for advanced non-small cell lung cancer: a prospective cohort study
2026 · Kazumasa Akagi, Shinnosuke Takemoto, et al. · BMC Pulmonary Medicine
Exploratory study to evaluate the combined effect of CBM588: Clostridium butyricum in platinum plus pemetrexed with pembrolizumab for non-small cell lung cancer—protocol of MIYABRO study
2026 · Ryuta Tagawa, Hirokazu Taniguchi, et al. · Translational Lung Cancer Research
Cellular Recovery and Therapeutic Rechallenge After Cancer Therapy-Induced Kidney Injury: Mechanistic Insights and Clinical Implications
2026 · Yosuke Dotsu, Kazumasa Akagi, et al. · Cells
Immunotherapy and the novel therapeutic development for small-cell lung cancer
2026 · Midori Matsuo, Hirokazu Taniguchi, et al. · Therapeutic Advances in Medical Oncology
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small cell lung cancer
2026 · Kazumasa Akagi, Hirokazu Taniguchi, et al. · Lung Cancer
Genomic Landscape of Pleural Mesothelioma in Japanese Patients: A Comprehensive Analysis Using Nationwide Database
2026 · Hirokazu Taniguchi, Kazumasa Akagi, et al. · SSRN Electronic Journal
Abstract 881: Innate immune cell-mediated anti-tumor activity against lung cancer and pleural mesothelioma cells
2025 · Hiromi Tomono, Kazumasa Akagi, et al. · Cancer Research
Immunoglobulin G4– Related Disease of the Sternoclavicular Joint: A Case Report
2025 · Remi Mizuta, Shinnosuke Takemoto, et al. · Clinical Case Reports
PDF
Genomic Landscape of Pleural Mesothelioma in Japanese Patients: A Comprehensive Analysis Using Nationwide Database
2025 · Hirokazu Taniguchi, Kazumasa Akagi, et al. · SSRN Electronic Journal
Works count: 18
Citation count: 15
H-index: 2
I10-index:
Year
Topic
Type